Article
Targeting the cancer cell cycle by cold atmospheric plasma
6 Sept 2012
Abstract excerpt
Cold atmospheric plasma (CAP), a technology based on quasi-neutral ionized gas at low temperatures, is currently being evaluated as a new highly selective alternative addition to existing cancer therapies. Here, we present a first attempt to identify the mechanism of CAP action. CAP induced a robust ~2-fold G2/M increase in two different types of cancer cells with different degrees of tumorigenicity. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
